Introduction {#sec1-1}
============

Leishmaniasis is a wide-ranging spectrum of diseases caused by parasites in the genus *Leishmania*. *Leishmania* spp. are insect-vectored intracellular protozoan parasites causing disease in humans and animals \[[@ref1]\]. The clinical manifestations of leishmaniasis usually depend on the species of *Leishmania* infecting the host. Parasites in the *Leishmania* *donovani* complex typically cause visceral leishmaniasis (VL), which leads to hepatosplenomegaly and can be fatal if left untreated. Cutaneous leishmaniasis is commonly caused by infection with *Leishmania major* and *Leishmania tropica*, whereas the mucocutaneous form is caused by *Leishmania braziliensis* \[[@ref2]\]. Dogs are considered the main reservoir of zoonotic species of *Leishmania*, including the *L. donovani* complex. In addition to dogs, however, many other wild animals are considered reservoir hosts such as wild canids, primates, and rodents \[[@ref3]\].

Leishmaniasis is transmitted by the bite of female phlebotomine sand flies \[[@ref4]\]. Flagellated promastigotes are injected in the skin of the host while the sand fly blood feeds. Once inside the host, promastigotes penetrate into macrophages and transform into spherical, non-flagellated amastigotes. Amastigotes multiply within macrophages of the host by binary fission. Eventually, infected macrophages burst open and release the amastigotes which may move to internal organs in the case of VL. Sand fly vectors ingest amastigotes while obtaining a blood meal from the infected host. Inside the insect vector, amastigotes change to promastigotes in the intestine. Some promastigotes attach to the epithelium of the foregut and others remain free and are transmitted to a susceptible host through the bite wound.

Leishmaniasis has been reported in the intertropical zones of Africa and America and into the temperate zones of South America, Europe, and Asia. Leishmaniasis is endemic in countries of South America, but little is known about leishmaniasis in neighboring Caribbean countries. Zeledon \[[@ref5]\] reported sporadic cases of CL in humans from Martinique, Trinidad, and Guadeloupe. VL is rare in the Caribbean \[[@ref5]\], but the first case of VL in Martinique was recently reported in an AIDS patient \[[@ref6]\].

Little is known of *Leishmania* spp. infections in Grenada, West Indies, and no human cases of VL have been reported. Rosypal *et al*. \[[@ref7]\] found no evidence of antibodies to VL parasites in 77 pet or stray dogs from Grenada. More recently, Kumthekar *et al*. \[[@ref8]\] detected antibodies specific for VL in stray dogs (3.7%) and owned dogs (2.0%) which indicated that dogs in Grenada are exposed at a low level to VL.

In addition to dogs, rodents are also important reservoir hosts for leishmaniasis. In the Caribbean, rats are suspected to be animal reservoir \[[@ref5],[@ref6],[@ref9],[@ref10]\], and rodent burrows are common breeding sites for phlebotomine sand flies \[[@ref11]\].

To the best of our knowledge, there is no report of *Leishmania* spp. infection in rats from Grenada. The current research aimed to determine the exposure of rats (*Rattus norvegicus*) to VL. in Grenada.

Materials and Methods {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

The project (detection of zoonotic pathogens in brown rats \[*R. norvegicus*\] in Grenada) was approved by the Institutional Animal Care and Use Committee (IACUC \# 16009-R) of the St. George's University, Grenada.

Study area {#sec2-2}
----------

Grenada is the southernmost country in the Caribbean Sea with an area of 348.5 km^2^ ([Figure-1](#F1){ref-type="fig"}). The country with low hills, small trees and shrubs, and tropical climate is most suitable for rats. The country is comprised six parishes: St. Patrick, St. Mark, St. Andrew, St. John, St. George, and St. David ([Figure-2](#F2){ref-type="fig"}). St. David and St. George parishes, which have a higher human population compared to other four parishes, were selected for the study ([Figure-2](#F2){ref-type="fig"}).

![Map showing location of Grenada in the Caribbean.](VetWorld-11-1321-g001){#F1}

![Grenada and parishes.](VetWorld-11-1321-g002){#F2}

Collection of rats {#sec2-3}
------------------

A total of 146 brown rats were collected live from May 1 to July 14, 2017, using traps (45 cm L ×15 cm W ×15 cm H) with cheese and various local fruits as bait. Attempts were made to trap the rats from and near the residential buildings. Traps were placed 2 days per week in the evening and visited next day morning. Traps with rats were covered with black cloth and transported to the necropsy laboratory of the School of Veterinary Medicine and transferred to the anesthesia machine. Rats were anesthetized using isoflurane in oxygen through portable vet anesthesia machine isoflurane vaporizer VET CE., manufacturer DRE (Avante Health Solution Company, USA.)

Collection of samples {#sec2-4}
---------------------

The anesthetized rats were examined for their physical health and weighed. Gender was also recorded. Rats \<100 g were grouped as young and over 100 g as adult, following the methodology used by Panti-May *et al*. \[[@ref12]\]. Blood was collected from the heart through the thoracic wall and rats were exsanguinated this way.

Sera were separated from the blood by centrifugation at 1500 g for 15 min at room temperature and stored at −80°C till tested.

Serology {#sec2-5}
--------

Rats were tested for antibodies to visceral *Leishmania* spp. with a commercially available immunochromatographic (ICT) dipstick test which is licensed for use in animals and humans (Kalazar Detect™ Canine Rapid Test, InBios International Ltd., Seattle, Washington). The qualitative ICT is based on recombinant antigen K39, an immunodominant amastigote protein, to detect antibodies specific to VL species \[[@ref13]\]. The ICT has been used in previous studies of rodents for detection of antibodies to VL \[[@ref14],[@ref15]\]. Rat sera were tested according to the manufacturer's test procedure. Briefly, rat serum samples were thawed, vortexed, and 20 µL of serum was placed on the sample pad of the dipstick. The ICT was then placed vertically in the well of a 96-well plate, and three drops (\~150 µL) of provided chase buffer were added to the base of the well to allow the serum to migrate up the dipstick. Results were collected in 10 min. The presence of a red or pink line in the control line and test line within the test area indicated a positive test. A single red or pink line in the control line area was a negative result. Antibody screening was performed at the Department of Natural Sciences and Mathematics, Johnson C. Smith University, Charlotte, North Carolina, USA.

Statistical analysis {#sec2-6}
--------------------

The data were analyzed by the Fisher's exact test, using GraphPad statistical software (<http://www.graphpad.com/quickcalcs/contingency2>).

Results and Discussion {#sec1-7}
======================

Antibodies to *Leishmania* spp. were detected in 34 of 146 brown rats (23.3%) (CI 95% from 16.70 to 30.99). The serological results according to parish, sex and age are presented in [Table-1](#T1){ref-type="table"}. No significant differences were found between sexes and young or adult rats. The prevalence between parishes (St. George and St. David) was also not significant.

###### 

Prevalence of visceral leishmaniasis in brown rats from Grenada according to parish, gender, and age.

  Parish        Tested   Positive (%)   Male   Female      Young   Adult                             
  ------------- -------- -------------- ------ ----------- ------- ----------- ---- ---------- ----- -----------
  St. Georges   71       14 (19.7)      35     6 (17.1)    36      8 (22.2)    12   2 (16.6)   58    12 (20.6)
  St. David     75       20 (26.6)      45     14 (31.1)   30      6 (20)      8    2 (25.0)   68    18 (26.4)
  Total         146      34 (23.3)      80     20 (25.0)   66      14 (21.2)   20   4 (20.0)   126   30 (23.8)

There are limited studies on leishmaniasis in *R. norvegicus*. Di Bella *et al*. \[[@ref16]\] reported a 33.3% seropositivity in *R. norvegicus* in Italy using indirect immunofluorescent techniques. In the same study, they found 57.55% seropositivity by IFA and 45% by molecular technique in *Rattus rattus*. A much lower prevalence of *Leishmania* spp. in 1 of 16 (6.25%) in *R. norvegicus* in Greece was found by Papdogiannakis *et al*. \[[@ref17]\]. They used molecular techniques for the diagnosis. A similar prevalence (23.3%) was reported by Caldert *et al*. \[[@ref18]\] in *R. rattus* in Brazil using ELISA test. However, they found a lower prevalence with indirect fluorescent antibody test (IFAT) (3.3%) and polymerase chain reaction (PCR) (7.1%). The results of previous researchers show that variation in the prevalence of *Leishmania* spp. in rats (*R. rattus and R. norvegicus*) differs with different diagnostic techniques and in different geographic regions.

VL can be diagnosed by cytologic or histopathologic identification of organisms, isolation of amastigotes, detection of serum antibodies, or PCR \[[@ref19]\]. Weese *et al*. \[[@ref20]\] recommended serological testing as the main component for the diagnosis of leishmaniasis. Previous serological studies of leishmaniasis in wildlife successfully used the same ICT utilized in the present study \[[@ref14],[@ref15]\]. The ICT used in this study is based on recombinant antigens, and it is considered an ideal diagnostic tool for leishmaniasis. Several studies \[[@ref21],[@ref22]\] using the recombinant antigen-based ICT demonstrated high specificity compared to traditional serological tests.

We did not observe any clinical signs of leishmaniasis in brown rats (*R. norvegicus*) under study. Milena *et al*. \[[@ref23]\] reported no apparent clinical signs of the disease in *R. rattus* in Turkey, although rats harbored live parasites capable of infecting sand flies. Similarly, Ashford \[[@ref24]\] reported no clinical signs in *R. norvegicus* but maintained longer infectivity for sand fly vectors. In other studies \[[@ref14],[@ref25]\], clinical signs were also not reported in rats positive for parasites.

Caldert *et al*. \[[@ref18]\] reported the incidence of leishmaniasis more frequently in adults compared to young rats, using ELISA. Their observations were in *R. rattus*. In the same study, authors reported that the positive proportion of female rats was higher than that of male rats taking into account all three diagnostic methods (ELISA, IFAT, and PCR). In our study, we did not find statistically significant differences in the age and sex of rats. Further, research involving a higher number of rat samples might answer this difference in sex and age.

Conclusion {#sec1-3}
==========

This is the first report of antibodies to VL in brown rats (*R. norvegicus*) from Grenada. The seroprevalence of VL found in the present study suggests that rats are frequently exposed to the parasite in Grenada. Although there is no report of human leishmaniasis in Grenada, the presence of moderate prevalence of antibodies against *Leishmania* spp. in *R. norvegicus* on the island could suggest rats may play a role in the transmission of VL to humans. Rats live in close proximity to humans, and they could play a role in the epidemiology of the parasite in Grenada and the Caribbean nations. Therefore, regular active surveillance for *Leishmania* spp. in rats and phlebotomine sand flies in Grenada is warranted. The results show that rats (*R. norvegicus*) in Grenada are exposed to *Leishmania* spp. The rats could play an important role in the transmission of leishmaniasis to humans and other animals in Grenada.
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